EventsThe 4th International Electronic Conference on Cancers
Published
This submission belongs to the session Session C. Cancer Immunology and Immunotherapy of the event The 4th International Electronic Conference on Cancers
Published date
02 Apr, 2024
Academic Editor
author-avatarVasso Apostolopoulos
Citation
Stavroula Kyrkou, Vassilios Bistas, Andreas G Tzakos, Targeting Gliomas, in Proceedings of The 4th International Electronic Conference on Cancers, 6 March–8 March 2024, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Targeting Gliomas

Stavroula Kyrkou 1
Vassilios Bistas 1
image
1. Department of Chemistry, University of Ioannina, Ioannina, Greece, Greece
Abstract

The prognosis for patients with GBM remains poor and novel therapeutic approaches to address this unmet clinical need are urgently required. In this work we will present our recent efforts to develop compounds to target and tackle gliomas. Furthermore, we will illustrate other approaches that we are following to develop novel theranostic compounds that could be able to target the specific tumor microenvironment.

Keywords
prognosis
gilomas
GBM
thernostic compounds
tumour microenvironment
Pulmonary tuberculosis: A comorbidity or misdiagnosis of primary lung cancer in Africa?
Cancer Immunotherapy three ways